Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002524940 | SCV003524935 | likely benign | not provided | 2022-08-12 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000509099 | SCV000607022 | not provided | Combined oxidative phosphorylation defect type 24 | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Prevention |
RCV004758030 | SCV005350730 | likely benign | NARS2-related disorder | 2024-05-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |